Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it
- 1 June 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 22 (15) , 1236-1249
Abstract
Attention-deficit hyperactivity disorder is a neurodevelopmental disorder diagnosed primarily in children, although it is also present in adults. Patients present inattention, impulsivity, and hyperactivity symptoms that create difficulties in their daily lives. Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms. Although generally effective and safe, pharmacological treatments have different effects among patients, including lack of response and adverse reactions. The reasons for these differences are not fully understood, but they may derive from the highly diverse etiology of ADHD. Strategies to guide optimal pharmacological treatment selection on the basis of individual patients’ physiological markers are being developed. In this review, we describe the main pharmacological ADHD treatments used and their main drawbacks. We present alternatives under study that would allow the customization of pharmacological treatments to overcome these drawbacks and achieve more reliable improvement of ADHD symptoms.Keywords
This publication has 100 references indexed in Scilit:
- Transgenic mouse models for ADHDCell and tissue research, 2013
- The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbensNeuropharmacology, 2012
- Effects of physical exercise on ADHD‐like behavior in male and female adolescent spontaneously hypertensive ratsDevelopmental Psychobiology, 2011
- Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD)Behavioural Brain Research, 2010
- Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: A model of attention deficit hyperactivity disorderNeuropharmacology, 2009
- Dopaminergic response to graded dopamine concentration elicited by four amphetamine dosesSynapse, 2009
- Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorderBehavioural Pharmacology, 2009
- Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive ratsBehavioural Pharmacology, 2008
- Atomoxetine versus Methylphenidate in Paediatric Outpatients with Attention Deficit Hyperactivity Disorder: A Randomized, Double-Blind Comparison TrialAustralian & New Zealand Journal of Psychiatry, 2007
- Intellectual functioning in adults with ADHD: A meta-analytic examination of full scale IQ differences between adults with and without ADHD.Psychological Assessment, 2006